These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15369425)

  • 1. Multicenter drug use evaluation of tamsulosin and availability of guidance criteria for nonformulary use in the veterans affairs health system.
    Burk M; Furmaga E; Dong D; Cunningham F
    J Manag Care Pharm; 2004; 10(5):423-32. PubMed ID: 15369425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of nonformulary use of PPIs and excess drug cost in a Veterans Affairs population.
    Ajumobi AB; Vuong R; Ahaneku H
    J Manag Care Pharm; 2012; 18(1):63-7. PubMed ID: 22235956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hyperplasia.
    Ohsfeldt RL; Kreder KJ; Klein RW; Chrischilles EA
    J Manag Care Pharm; 2004; 10(5):412-22. PubMed ID: 15369424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in Formulary Management Practices Within the Department of Veterans Affairs Health Care System.
    Radomski TR; Good CB; Thorpe CT; Zhao X; Marcum ZA; Glassman PA; Lowe J; Mor MK; Fine MJ; Gellad WF
    J Manag Care Spec Pharm; 2016 Feb; 22(2):114-20. PubMed ID: 27015250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finasteride and tamsulosin used in benign prostatic hypertrophy: a review of the prescription-event monitoring data.
    Shakir S; Pearce G; Mann RD
    BJU Int; 2001 Jun; 87(9):789-96. PubMed ID: 11412215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ; Guo YL; Gu FL
    J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamsulosin for benign prostatic hyperplasia.
    Wilt TJ; Mac Donald R; Rutks I
    Cochrane Database Syst Rev; 2003; (1):CD002081. PubMed ID: 12535426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between tamsulosin and serious ophthalmic adverse events in older men following cataract surgery.
    Bell CM; Hatch WV; Fischer HD; Cernat G; Paterson JM; Gruneir A; Gill SS; Bronskill SE; Anderson GM; Rochon PA
    JAMA; 2009 May; 301(19):1991-6. PubMed ID: 19454637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Blocker and Risk of Dementia in Patients with Benign Prostatic Hyperplasia: A Nationwide Population Based Study Using the National Health Insurance Service Database.
    Tae BS; Jeon BJ; Choi H; Cheon J; Park JY; Bae JH
    J Urol; 2019 Aug; 202(2):362-368. PubMed ID: 30840545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamsulosin for the treatment of benign prostatic hypertrophy.
    Lee M
    Ann Pharmacother; 2000 Feb; 34(2):188-99. PubMed ID: 10676828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Our experience with the treatment of benign prostatic hyperplasia (BPH) with tamsulosin.
    Cervenakov I; Fillo J
    Bratisl Lek Listy; 2001; 102(3):138-41. PubMed ID: 11433602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term, open-label, phase III multicenter study of tamsulosin in benign prostatic hyperplasia.
    Narayan P; Lepor H
    Urology; 2001 Mar; 57(3):466-70. PubMed ID: 11248621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].
    Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP;
    Prog Urol; 2002 Jun; 12(3):384-92; discussion 394-4. PubMed ID: 12189744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
    Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP
    Eur Urol; 2002 May; 41(5):497-506; discussion 506-7. PubMed ID: 12074791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacy Benefits Management in the Veterans Health Administration Revisited: A Decade of Advancements, 2004-2014.
    Aspinall SL; Sales MM; Good CB; Calabrese V; Glassman PA; Burk M; Moore VR; Neuhauser MM; Golterman L; Ourth H; Valentino MA; Cunningham FE
    J Manag Care Spec Pharm; 2016 Sep; 22(9):1058-63. PubMed ID: 27579828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients.
    Okada H; Kamidono S; Yoshioka T; Okuyama A; Ozono S; Hirao Y; Okajima E; Yamamoto K; Kishimoto T; Park Y; Kurita T
    BJU Int; 2000 Apr; 85(6):676-81. PubMed ID: 10759664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Study Group. Benign prostatic hyperplasia.
    Tsujii T
    Int J Urol; 2000 Jun; 7(6):199-205. PubMed ID: 10843450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamsulosin: current clinical experience.
    O'Leary MP
    Urology; 2001 Dec; 58(6 Suppl 1):42-8; discussion 48. PubMed ID: 11750250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia.
    Kawabe K
    Br J Urol; 1995 Jul; 76 Suppl 1():63-7. PubMed ID: 7544217
    [No Abstract]   [Full Text] [Related]  

  • 20. Terazosin for treating symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects.
    Wilt TJ; Howe W; MacDonald R
    BJU Int; 2002 Feb; 89(3):214-25. PubMed ID: 11856101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.